The community-acquired pneumonia symptom questionnaire: A new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia

Chest

Volumn 122, Issue 3, 2002, Pages 920-929

  Lamping, Donna L ^a   Schroter, Sara ^a   Marquis, Patrick ^b   Marrel, Alexia ^b   Duprat Lomon, Isabelle ^c   Sagnier, Pierre Philippe ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MAPI VALUES   (United States)

^c Bayer plc UK   (United Kingdom)

Author keywords

Community acquired pneumonia; Outcomes; Patient based assessment; Questionnaire; Symptoms

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; MOXIFLOXACIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELIABILITY; SYMPTOM; VALIDATION PROCESS;

EID: 0036384231     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.3.920     Document Type: Article

References (46)

1. Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community acquired pneumonia. Clin Ther 1998; 20:820-837
2. Guidelines for the management of community acquired pneumonia in adults admitted to hospital: The British Thoracic Society. Br J Hosp Med 1993; 49:346-350
3. Marrie TJ. Community acquired pneumonia: epidemiology, etiology, treatment. Infect Dis Clin North Am 1998; 12:723-740
4. Bartlett JG, Mundy LM. Community acquired pneumonia. N Engl J Med 1995; 333:1618-1624
5. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31:347-382
6. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31:383-421
7. ERS Task Force Report: guidelines for management of adult community-acquired lower respiratory tract infections; European Respiratory Society. Eur Respir J 1998; 11:986-991
8. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754
9. Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneu-mococcal resistance. Arch Intern Med 2000; 160:1399-1408
10. Gleason PP, Kapoor WN, Stone RA, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 1997; 278:32-39
11. Suchyta MR, Dean NC, Narus S, et al. Effects of a practice guideline for community-acquired pneumonia in an outpatient setting. Am J Med 2001; 110:306-309
12. Dean NC, Silver MP, Bateman KA, et al. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 2001; 110:451-457
13. Roa CC, Dantes RB. Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. Drug Res 1995; 45:267-272
14. Lim WS, Macfarlane JT, Boswell TCJ, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56:296-301
15. Petitpretz P, Arvis P, Marel M, et al. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired pneumococcal pneumonia in adults. Chest 2001; 119:185-195
16. Metlay JP, Schulz R, Li Y-H, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157:1453-1459
17. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000; 283:749-755
18. Fine MJ, Pratt HM, Obrosky DS, et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med 2000; 109:378-385
19. Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med 1997; 12:423-430
20. Fitzpatrick R, Fletcher A, Gore S, et al. Quality of life measures in health care. I: Applications and uses in assessment. BMJ 1992; 305:1074-1077
21. Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University Press, 1992
22. Quality of life and clinical trials [editorial]. Lancet 1995; 346:1-2
23. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York, NY: McGraw Hill, 1994
24. Jenkinson C, ed. Measuring health and medical outcomes. London, UK: UCL Press, 1994
25. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed. Oxford, UK: Oxford University Press, 1995
26. Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality-of-life and health status instruments: development of scientific criteria. Clin Ther 1996; 18:979-992
27. McDowell I, Jenkinson C. Development standards for health measures. J Health Serv Res Policy 1996; 1:238-246
28. Lamping DL, Rowe P, Black N, et al. Development and validation of an audit instrument: the Prostate Outcomes Questionnaire. Br J Urol 1998; 82:49-62
29. Lamping DL, Rowe P, Clarke A, et al. Development and validation of the Menorrhagia Outcomes Questionnaire. Br J Obstet Gynaecol 1998; 105:766-779
30. Foss AJE, Lamping DL, Schroter S, et al. Development and validation of a patient-based measure of outcome in ocular melanoma. Br J Ophthalmol 2000; 84:347-351
31. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. 2nd ed. Oxford, UK: Oxford University Press, 1996
32. Bowling A. Measuring disease: a review of disease-specific quality of life measurement scales. 2nd ed. Buckingham, UK: Open University Press, 2001
33. Bowling A. Measuring health: a review of quality of life measurement scales. 2nd ed. Milton Keynes, UK: Open University Press, 1997
34. Acquadro C, Jambon B, Ellis D, et al. Language and translation issues. In: Spilker B, ed. Quality of life and pharmaco-economics in clinical trials. Philadelphia, PA: Lippincott-Raven 1996, 575-585
35. Höffken G, Corris PA, Muir JF, et al. Assessment of the management of community-acquired pneumonia (CAP): a comparison of moxifloxacin (MXF) to standard first-line oral monotherapy or a combination regimen. Presented at: 41st International Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 2001
36. Fine MJ, Auble TE, Yealey DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
37. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston, MA: The Health Institute, 1994
38. Rosen RC, Riley A, Wagner G, et al. The international index of erectile dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49:822-830
39. Ware JE Jr, Snow KK, Kosinski M, et al. SF-36 Health Survey: manual and interpretation guide. Boston, MA: The Health Institute, 1993
40. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985; 38:517-524
41. Juniper EF, Guyatt GH, Ferrie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147:832-838
42. Cleary PD. Subjective and objective measures of health: which is better? J Health Serv Res Policy 1997; 2:3-4
43. Lamping DL, Schroter S, Sagnier PP, et al. Psychometric evaluation of the CAP-Sym questionnaire: a new, patient-based measure of symptoms in community-acquired pneumonia. Value Health 2001; 4:65
44. Cronbach LJ. Coefficient α and the internal structure of tests. Psychometrika 1951; 16:297-334
45. Cohen J. Statistical power analysis for the behavioral sciences. New York, NY: Academic Press, 1977
46. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27(3 suppl):S178-S189